Investing.com - Financial Markets Worldwide

Tempus AI Inc DRC (TEMm)

Buenos Aires
Currency in ARS
11,330.00
+60.00(+0.53%)
Closed·
TEMm is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
10,750.0011,360.00
52 wk Range
5,160.0013,350.00
Key Statistics
Edit
Bid/Ask
11,000.00 / 14,000.00
Prev. Close
11,270
Open
11,180
Day's Range
10,750-11,360
52 wk Range
5,160-13,350
Volume
2.91K
Average Volume (3m)
7.36K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
TEMm Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 12
Stock has taken a big hit over the last week
Unlock InvestingPro

Tempus AI Inc DRC Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaboration agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. and Whitehawk Therapeutics, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
2400
Market
Argentina

Compare TEMm to Peers and Sector

Metrics to compare
TEMm
Peers
Sector
Relationship
P/E Ratio
−76.4x−0.6x−0.7x
PEG Ratio
−0.85−0.020.00
Price/Book
49.3x3.0x2.6x
Price / LTM Sales
16.0x2.2x3.4x
Upside (Analyst Target)
-5.7%39.2%
Fair Value Upside
Unlock24.6%6.1%Unlock

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
-0.25 / --
Revenue / Forecast
314.64M / --
EPS Revisions
a
a
Unlock
Last 90 days

TEMm Income Statement

People Also Watch

Tempus AI
87.78
TEM
-3.56%
Rigetti Computing
46.380
RGTI
-3.31%
UiPath
15.44
PATH
-3.08%
Eli Lilly
802.83
LLY
-2.02%
MercadoLibre
2,024.98
MELI
-0.88%

FAQ

What Stock Exchange Does Tempus AI DRC Trade On?

Tempus AI DRC is listed and trades on the Buenos Aires Stock Exchange stock exchange.

What Is the Stock Symbol for Tempus AI DRC?

The stock symbol for Tempus AI DRC is "TEMm."

What Is the Tempus AI DRC Market Cap?

As of today, Tempus AI DRC market cap is 22.23T.

What Is Tempus AI DRC's Earnings Per Share (TTM)?

The Tempus AI DRC EPS (TTM) is -1.18.

From a Technical Analysis Perspective, Is TEMm a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Tempus AI DRC Stock Split?

Tempus AI DRC has split 0 times.

How Many Employees Does Tempus AI DRC Have?

Tempus AI DRC has 2400 employees.

What is the current trading status of Tempus AI DRC (TEMm)?

As of 18 Oct 2025, Tempus AI DRC (TEMm) is trading at a price of 11,330.00, with a previous close of 11,270.00. The stock has fluctuated within a day range of 10,750.00 to 11,360.00, while its 52-week range spans from 5,160.00 to 13,350.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.